| Literature DB >> 30651407 |
Ana Vanessa Bataller-Cervero1, Juan Rabal-Pelay1, Luis Enrique Roche-Seruendo1, Belén Lacárcel-Tejero2, Andrés Alcázar-Crevillén2, Jose Antonio Villalba-Ruete3, Cristina Cimarras-Otal1.
Abstract
Low back pain (LBP) is a common problem in manufacturing workers. Several strategies have been proposed in order to reduce the pain and/or improve functionality. Among them, lumbar supports are a common solution prescribed for lumbar pain relief. Most of the studies in the literature only consider subjective sensations of the workers for evaluation assessment. This study applies biomechanical tests (a flexion-relaxation test and a functional movement evaluation test) to analyse the effectiveness of flexible lumbar supports in functionality and disability versus placebo intervention, consisting of kinesiotape placed on the low back without any stress. 28 workers participated in the study, randomised in control and intervention groups with a two months' intervention. None of the biomechanical tests showed statistical differences in between-groups pre-post changes. No benefits of wearing a flexible lumbar support during the workday have been found in these assembly-line workers versus placebo intervention.Entities:
Keywords: Flexible lumbar belt; Flexion-relaxation phenomenon; Functionality; Lumbar pain; Manufacturing workers
Mesh:
Year: 2019 PMID: 30651407 PMCID: PMC6783285 DOI: 10.2486/indhealth.2018-0179
Source DB: PubMed Journal: Ind Health ISSN: 0019-8366 Impact factor: 2.179
Fig. 1.a) EMG probes and reflective markers location for FRP. b) Reflective markers location for functional test in posterior frontal and sagittal planes.
Fig. 2.a) Kinesiotape placement. b) lumbar support.
Baseline characteristics of the sample
| Intervention group (n=14) | Control group (n=14) | ||
|---|---|---|---|
| Age (yr), Mean (SD) | 43 (7) | 41 (7) | |
| Sex, N (%) | |||
| Male | 11 (78.5) | 11 (78.5) | |
| Female | 3 (21.5) | 3 (21.5) | |
| Height (cm), Mean (SD) | 172 (10.0) | 173 (10.1) | |
| Weight (kg), Mean (SD) | 79.1 (13.5) | 82.2 (20.0) | |
| BMI, Mean (SD) | 26.4 (2.8) | 23.3 (6.1) | |
| Lumbar pain, Mean (SD) | 3.6 (0.8) | 2.7 (1.7) | |
| 12 months LBP, N (%) | 100 (0) | 100 (0) | |
BMI: Body Mass Index; LBP: Low Back Pain.
Mean (SD) of biomechanical test variables in control and intervention groups in pre and post and effect size of within-group change (with 90% confidence interval)
| Intervention group (n=14) | Control group (n=14) | |||||
|---|---|---|---|---|---|---|
| Pre | Post | ES (CL90%) | Pre | Post | ES (CL90%) | |
| MFA | 75.3 (8.2) | 73.6 (9.2) | −0.2 (−0.8; 0.4) | 77.5 (9.9) | 74.6 (10.4) | −0.3 (−0.9; 0.3) |
| El L1–L5 | 64.3 (13.9) | 65.6 (13.1) | 0.1 (−0.5; 0.7) | 69.0 (12.9) | 67.7 (12.5) | −0.1 (−0.7; 0.5) |
| FV (º/s) | 22.7 (4.1) | 24.3 (8.2) | 0.2 (−0.4; 0.8) | 25.8 (3.9) | 27.1 (8.0) | 0.2 (−0.4; 0.8) |
| LL-F/R | 1.3 (0.4) | 1.9 (0.7)* | 1.0 (0.3; 1.7) | 1.1 (0.6) | 1.7 (0.8)* | 0.8 (0.1; 1.4) |
| LR-F/R | 1.9 (0.5) | 2.6 (1.0)* | 0.8 (0.1; 1.3) | 1.6 (0.8) | 2.2 (1.3) | 0.5 (−0.0; 1.1) |
| ML-F/R | 2.8 (1.3) | 3.0 (2.3) | 0.1 (−0.5; 0.7) | 1.9 (1.0) | 2.4 (1.5) | 0.3 (−0.2; 1) |
| MR-F/R | 3.0 (1.4) | 2.5 (1.2) | −0.3 (−1.0; 0.2) | 2.3 (1.4) | 2.8 (2.3) | 0.2 (−0.3; 0.8) |
| LNI | 96.2 (2.5) | 96.9 (2.4) | 0.2 (−0.3; 0.9) | 97.1 (2.7) | 98.0 (1.6) | 0.4 (−0.2; 1) |
| CI | 94.0 (4.8) | 92.8 (6.5) | −0.2 (−0.8; 0.4) | 95.0 (4.9) | 96.5 (4.3) | 0.3 (−0.3; 0.9) |
| SSI | 95.5 (3.2) | 96.0 (3.0) | 0.1 (−0.4; 0.8) | 97.0 (3.4) | 97.7 (2.1) | 0.2 (−3; 0.8) |
| WI | 98.3 (2.6) | 98.5 (1.3) | 0.1 (−0.5; 0.7) | 97.8 (2.5) | 98.7 (1.5) | 0.4 (−0.2; 1.5) |
*p<0.05 in the statistical test between pre and post evaluation. CL: Confidence limit. MFA: maximum flexion angle; El L1–L5: elongation between L1 and L5; FV: forward velocity; LL-F/R and LR-F/R: left and right longissimus flex-relax ratio respectively; ML-F/R and MR-F/R: left and right multifidus flex-relax ratio respectively; LNI: lumbar normality index; CI: collaboration index; SSI: sit-to-stand normality index; LWI: lifting weight normality index; ES: effect size.
Between-group pre-post mean differences and effect size (ES) (with 90% confidence interval)
| Intervention group (n=14) | Control group (n=14) | Intervention-control | |
|---|---|---|---|
| Pre-Post | Pre-Post | ES (CL90%) | |
| MFA | 1.7 | 2.9 | 0.1 (−0.7; 0.4) |
| El L1–L5 | −1.3 | 1.3 | −0.1 (−0.8; 04) |
| FV (º/s) | −1.6 | −1.3 | −0.0 (−0.6; 0.5) |
| LL-F/R | −0.6 | −0.6 | 0.0 (−0.6; 0.6) |
| LR-F/R | −0.7 | −0.6 | −0.1 (−0.7; 0.4) |
| ML-F/R | −0.2 | −0.5 | 0.2 (−0.3; 0.8) |
| MR-F/R | 0.5 | −0.5 | 0.6 (0.0; 1.3) |
| LNI | −0.7 | 0.9 | 0.0 (−0.5; 0.7) |
| CI | 1.2 | −1.5 | 0.5 (−0.0; 1.1) |
| SSI | −0.5 | −0.7 | 0.0 (−0.5; 0.6) |
| LWI | −0.2 | −0.9 | 0.2 (−0.3; 0.8) |
MFA: maximum flexion angle; El L1–L5: elongation between L1 and L5; FV: forward velocity; LL-F/R and LR-F/R: left and right longissimus flex-relax ratio respectively; ML-F/R and MR-F/R: left and right multifidus flex-relax ratio respectively; LNI: lumbar normality index; CI: collaboration index; SSI: sit-to-stand normality index; LWI: lifting a weight normality index; ES: effect size.